Fate Therapeutics (FATE) Shares Outstanding (Diluted) (2020 - 2026)
Fate Therapeutics' Weighted Average Shares Outstanding (Diluted) was 120.4 million in Q2 2026, up 1.6% from 118.53 million a year earlier and up 0.3% from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
For FY2025, Weighted Average Shares Outstanding (Diluted) at Fate Therapeutics came in at 118.79 million, up 4.5% from FY2024.
- Weighted Average Shares Outstanding (Diluted) has now increased for five consecutive years, with a five-year compound annual growth rate of 7.6% (FY2020 to FY2025).
- In earlier years, Weighted Average Shares Outstanding (Diluted) was 113.69 million in FY2024 (+15.5%), 98.41 million in FY2023 (+1.6%), 96.83 million in FY2022 (+2.2%) and 94.75 million in FY2021 (+15.0%).
- The Q2 2026 figure marks the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q4 2020.
- Compared with a year earlier, Weighted Average Shares Outstanding (Diluted) has increased for 19 straight quarters, with growth averaging 7.7% over the last eight quarters.
- Across the past five years, year-over-year growth in Weighted Average Shares Outstanding (Diluted) ran from 0.9% in Q2 2025 to 19.5% in Q3 2024.
- Per Business Quant data, FATE's Weighted Average Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 120.03 million (Q1 2026), 118.79 million (Q4 2025) and 119 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Fate Therapeutics | 215.18 Mn | 76.08 Mn | - | 123.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 123.66 Mn |
| Jun 30, 2026 | 120.40 Mn |
| Mar 31, 2026 | 120.03 Mn |
| Dec 31, 2025 | 118.79 Mn |
| Sep 30, 2025 | 119.00 Mn |
| Jun 30, 2025 | 118.53 Mn |
| Mar 31, 2025 | 118.38 Mn |
| Dec 31, 2024 | 113.69 Mn |
| Sep 30, 2024 | 117.77 Mn |
| Jun 30, 2024 | 117.47 Mn |
| Mar 31, 2024 | 101.10 Mn |
| Dec 31, 2023 | 98.41 Mn |
| Sep 30, 2023 | 98.57 Mn |
| Jun 30, 2023 | 98.40 Mn |
| Mar 31, 2023 | 98.05 Mn |
| Dec 31, 2022 | 96.83 Mn |
| Sep 30, 2022 | 97.02 Mn |
| Jun 30, 2022 | 96.70 Mn |
| Mar 31, 2022 | 96.34 Mn |
| Dec 31, 2021 | 94.75 Mn |
API Access
Fate Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();